6 completed, 2 recruiting, 1 unknown. 3 Phase 2, 2 Not applicable, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Hyperkinesis: new trials by email Literature Review of Hyperkinesis trials Research Report on Hyperkinesis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. Antisense oligonucleotide treatment (ASO) - GNAO1, Epilepsy | Phase 1 / Phase 2 | Recruiting | Pirogov Russian National Research Medical University | 5 | 2025-09-09 | 2026-01-23 |
| Parkinsonism-Related Oscillations in the Cortico-Basal Ganglia-Thalamic Network During Movement: Beyond the Frequency Range Electrophysiological recordings - Parkinson Disease, Hyperkinesis | Not applicable | Recruiting | University Hospital, Bordeaux | 20 | 2025-04-16 | 2025-05-02 |
| Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis Oxymetazoline 0.1% (Pf) Oph Soln Ud, Preservative free lubricating drops - Blepharoptosis, Synkinesis | Phase 3 | Completed | Milton S. Hershey Medical Center | 36 | 2024-01-11 | 2026-03-09 |
| Abnormal Hyperkinetic Movements Post Acute Stroke Neurology Department | Unknown | Centre Hospitalier de Saint-Denis | 15 | 2022-05-23 | 2022-05-25 | |
| Intensive Therapy for Children With Microcephaly, Hyperkinetic Movements, or Global Developmental Delay Acquire Therapy - Microcephaly, Hyperkinesis With Developmental Delay | Not applicable | Completed | Virginia Polytechnic Institute and State University | 4 | 2019-04-30 | 2022-10-13 |
| Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock Septic Shock, Echocardiography | Completed | University Hospital, Limoges | 440 | 2017-01-01 | 2026-03-19 | |
| Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial Tipepidine Hibenzate, Placebo - Attention Deficit Disorder With Hyperactivity Disease, Hyperkinesis | Phase 1 / Phase 2 | Completed | Chiba University | 21 | 2015-06-11 | 2019-03-19 |
| Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients Lobeline sulfate, Methylphenidate HCl, Placebo - Attention Deficit Disorder With Hyperactivity | Phase 2 | Completed | Yaupon Therapeutics | 13 | 2008-07-01 | 2013-06-20 |
| Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders Hyperkinesis | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 40 | 2003-01-01 | 2008-03-04 |
Attention Deficit and Disruptive Behavior Disorders (2) · Dyskinesias (2) · Attention Deficit Disorder with Hyperactivity (1) · Blepharoptosis (1) · Channelopathies (1) · Chorea (1) · Epilepsy (1) · Facial Paralysis (1) · Hypokinesia (1) · Learning Disabilities (1) · Microcephaly (1) · Neurodevelopmental Disorders (1) · Neurologic Manifestations (1) · Parkinson Disease (1)
Nervous System Diseases (9) · Pathological Conditions, Signs and Symptoms (9) · Signs and Symptoms (9) · Neurologic Manifestations (8) · Dyskinesias (7) · Central Nervous System Diseases (5) · Brain Diseases (3) · Mental Disorders (3) · Movement Disorders (3) · Neurodevelopmental Disorders (2) · Pathologic Processes (2) · Basal Ganglia Diseases (1) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1) · Communication Disorders (1)
Lobeline (1) · Methylphenidate (1) · Oxymetazoline (1) · tipepidine (1)
Centre Hospitalier de Saint-Denis (1) · Chiba University (1) · Milton S. Hershey Medical Center (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Pirogov Russian National Research Medical University (1) · University Hospital, Bordeaux (1) · University Hospital, Limoges (1) · Virginia Polytechnic Institute and State University (1) · Yaupon Therapeutics (1)
United States (4) · France (3) · Japan (1) · Russia (1)
Catherine A. Martin, MD (1) · Elena D Belousova, Prof (1) · Jessyka Lighthall, MD (1) · Stephanie C DeLuca, PhD (1)
PMID 10699392, PMID 23602779, PMID 27476417, PMID 39774865, PMID 7737242
R43MH081553 (1)